Aeterna zentaris Contact Number

All Time Past 24 Hours Past Week Past month Post Your Comments?

About Aeterna zentaris Contact Number

Phone Number 418-652-8525 AEterna Zentaris Inc. is a drug development company specialized in oncology and endocrine therapy. The Company''s product pipeline encompasses compounds at all stages of development, from drug discovery through marketed products.

Contact US: https://www.crunchbase.com/organization/aeterna-zentaris

What are the shareholder dilution claims against aeterna zentaris?

Aeterna Zentaris Inc. (AEZS) Shareholder Dilution Claims: The investigation concerns whether Aeterna Zentaris and its board of directors violated the federal securities laws and/or breached their fiduciary duties to shareholders by failing to: Hold shareholder value to a maximum, instead - diluted shares by over 400% in less than 8 months.

How much is aeterna zentaris worth?

The offering is expected to result in gross proceeds to Aeterna Zentaris of approximately $4.5 million. Aeterna Zentaris will also issue to the purchasers unregistered warrants to purchase up to an aggregate of 2,608,696 common shares.

What is warrant on aeterna zentaris?

Aeterna Zentaris will also issue to the purchasers unregistered warrants to purchase up to an aggregate of 2,608,696 common shares. The warrants will be exercisable for a period of five and one-half years, exercisable immediately following the issuance date and have an exercise price of $1.20 per common share.

Who is the chief executive officer of aeterna?

Let’s GOOOOOO !!! Dr. Klaus Paulini, Chief Executive Officer of Aeterna, will present at NobleCon17 - Noble Capital Markets’ Seventeenth Annual Investor Conference on Wednesday, January 20, 2021 at 12:00 PM ET.

Company

48 People Used

See More ››

AEterna Zentaris (AEZS) Company Profile & Overview Stock

Company profile for AEterna Zentaris, including a description, list of executives, contact details and other key facts. Company profile for AEterna Zentaris, including a description, list of executives, contact details and other key facts. CUSIP Number: 007975105: ISIN Number: CA0079754028: Company Description.

View Contact ››

Purchased

46 People Used

See More ››

Aeterna Zentaris, Inc. Securities Litigation

Jersey (the “Court”) if, during the period from August 30, 2011 through November 6, 2014, both dates inclusive (the “Class Period”), you purchased Aeterna Zentaris, Inc. (“Aeterna” or the “Company”) securities on a U.S. Exchange or in a U.S. transaction and …

View Contact ››

Aeterna

60 People Used

See More ››

Aeterna Zentaris, Inc.

Aeterna Zentaris, Inc. 1405, Boul. Du Parc-technologique Quebec G1p 4p5 CANADA

View Contact ››

Study

34 People Used

See More ››

CGHD

*Navigant study 2009, TVG study 2017, Huron Consulting study 2018

View Contact ››

Commission

55 People Used

See More ››

Aeterna Zentaris Inc. 2021 Foreign Issuer Report 6 K

Commission File Number: 001-38064 . Aeterna Zentaris Inc. (Translation of registrant’s name into English) 315 Sigma Drive, Summerville, South Carolina, USA 29486 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F [ ] Form 40-F [X]

View Contact ››

Payout

109 People Used

See More ››

AEZS: Dividend Date & History for Aeterna Zentaris Inc

Aeterna Zentaris Inc. Dividend policy None Price as of: MAY 18, 02:55 PM EDT $0.89 +0.04 +4.71% Consecutive Years of Dividend Increase is the number of years in a row in which there has been at least one payout increase and no payout decreases. Contact us About us FAQ DARS Ratings

View Contact ››

Zentaris

56 People Used

See More ››

Aeterna Zentaris (AEZS) Recent Earnings

Aeterna Zentaris (AEZS) Recent Earnings. Aeterna Zentaris (AEZS) reported a Quarter December 2020 loss of $0.02 per share on revenue of $2.4 million.. Revenue grew 13,044.4% on a year-over-year basis. AEterna Zentaris Inc is a specialty biopharmaceutical company engaged in developing novel treatments in oncology, endocrinology and women'' health.

View Contact ››

AETERNA

186 People Used

See More ››

AETERNA ZENTARIS ANNOUNCES DISTRIBUTION AGREEMENT …

AETERNA ZENTARIS ANNOUNCES DISTRIBUTION AGREEMENT WITH MEGAPHARM LTD. TO COMMERCIALIZE MACIMORELIN IN ISRAEL AND THE PALESTINE AUTHORITY CHARLESTON, S.C, June 25, 2020 (GLOBE NEWSWIRE) -- Aeterna

View Contact ››

Aeterna

60 People Used

See More ››

Aeterna Zentaris Target Price for 2022 AEZS

Aeterna Zentaris'' current and average target prices are 0.87 and 4.50, respectively. The current price of Aeterna Zentaris is the price at which Aeterna Zentaris is currently trading. On the other hand, Aeterna Zentaris'' target price is what analysts think the stock is worth or could sell for in the future.

View Contact ››

Registrant

179 People Used

See More ››

Aeterna Zentaris Inc. (Form: 6 K, Received: 01/26/2021 17

Commission File Number: 001-38064 . Aeterna Zentaris Inc. (Translation of registrant’s name into English) 315 Sigma Drive, Summerville, South Carolina, USA 29486 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

View Contact ››

Company

101 People Used

See More ››

AEterna Zentaris GmbH, Frankfurt

AEterna Zentaris GmbH has its registered office in Frankfurt, Germany. Its current status is listed as active. The company is registered at the Trade register at the local court of Frankfurt am Main with the legal form of Private limited company (number HRB 56000).

View Contact ››

Please leave your comments here:

Popular Brands

Amazon
Asml
Abbvie
Apple
Att
Acc
Amd
Abb
Aak
Agco